GlassScriptPhysician profile
Fred I Lipschutz
NPI 1295751121
$2,116.94
in general payments reported to CMS, 2019-2025
25 companies · $219 in 2025
The $219 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $253 · 2021: $297 · 2022: $390 · 2023: $175 · 2024: $330 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $363.68 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $288.45 | 2021-2025 | Qelbree, Qelbree |
| Sanofi-Aventis U.S. LLC | $140.82 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $138.26 | 2019-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $127.97 | 2019-2021 | |
| Pfizer INC. | $127.68 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $117.14 | 2022-2024 | Flumist Quadrivalent |
| Cranial Technologies, INC | $106.91 | 2019-2025 | Doc Band |
| Genentech USA, INC. | $95.86 | 2020-2022 | |
| Glaxosmithkline, LLC. | $90.28 | 2019-2024 | Bexsero |
| Tris Pharma INC | $86.82 | 2019-2021 | |
| Sobi, INC | $75.00 | 2019-2022 | |
| Corium, LLC | $57.83 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $51.78 | 2025 | Jornay Pm |
| Qol Medical, LLC | $34.46 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $29.70 | 2019 | |
| Kaleo, INC. | $29.51 | 2019-2022 | |
| Phadia US INC. | $27.54 | 2019-2020 | |
| Qiagen, LLC | $22.18 | 2022 | |
| Neos Therapeutics, LP | $21.19 | 2019 | |
| Shire North American Group INC | $19.82 | 2019 | |
| Pbg Puerto Rico LLC | $18.19 | 2021 | |
| Galderma Laboratories, L.P. | $16.45 | 2021 | |
| Hologic Sales and Service, LLC | $15.13 | 2019 | |
| Alk-Abello, INC | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Lipschutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.